tbuckley/cabot-search huggingface dataset:
Estimated Cost of Sunburn-Associated Visits to US Hospital Emergency Departments
Authors: Gery P. Guy, Zahava Berkowitz, Meg Watson
Journal: JAMA Dermatology (2016)

Estimated Cost of Sunburn-Associated Visits to US Hospital Emergency DepartmentsSunburn, a clear indicator of overexposure to UV radiation, increases the risk of skin cancer.The estimated prevalence of sunburn in the United States is high; 37.1% of adults and 55.8% of youth reported 1 or more sunburns in the past 12 months. 1,2ur study provides, to our knowledge, the first national estimates of sunburn-associated visits to US emergency departments, as well as their costs.Methods | We analyzed data from the 2013 Nationwide Emergency Department Sample (NEDS) from the Healthcare Costs Table.Characteristics of Sunburn-Associated Visits to Emergency Departments in the United States, 2013 Nationwide Emergency Department Sample a Characteristic No. % (95% CI) Patient characteristics Age, y
Improved Outcome of Patients with Invasive Pulmonary Fungal Infection Complicated by Respiratory Failure Due to the Use of New Antimycotis Agens and Early Tracheostomy after Allogeneic Transplantation.
Authors: Michael Koldehoff, Ahmet H. Elmaagacli, Nina K. Steckel, Rudolf Trenschel, Michal Hlinka, Markus Ditschkowski, Harald Biersack, Dietrich W. Beelen
Journal: Blood (2005)
The Epigenetic Repression of Mir-375 Is the Dominant Mechanism for the Constitutive Activation of PDPK1/RSK2 Signaling Axis in Multiple Myeloma
Authors: Shotaro Tatekawa, Junya Kuroda, Yoshiaki Chinen, Yuji Shimura, Hisao Nagoshi, Tsutomu Kobayashi, Eri Kawata, Nobuhiko Uoshima, Hiroshi Handa, Masafumi Taniwaki
Journal: Blood (2015)
Autologous Stem Cell Transplantation (ASCT) for Patients Aged 60 Years or Older with Classical Hodgkin Lymphoma : A Retrospective Analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
Authors: Aspasia Stamatoullas, Pauline Brice, Mor Seny Gueye, Patrice Chevallier, Reda Bouabdallah, Stephanie Nguyenquoc, Sylvie Francois, Pascal Turlure, Patrice Ceballos, Helene Monjanel, Jean-Henri Bourhis, Gaelle Guillerm, Mohamad Mohty, Pierre Biron, Jérôme Cornillon, Catherine Cordonnier, Caroline Bonmati, Reza Tabrizi, Anne Huynh, Marc Bernard, Denis Caillot, Régis Peffault de Latour, Hervé Tilly
Journal: Blood (2014)
A Novel Fusion, KIAA0379 (Ankyrin Repeat Domain 28) to NUP98 in an Adult MDS/AML with a t(3;5;11)(p25;q35;p15).
Authors: Maho Ishikawa, Fumiharu Yagasaki, Daisuke Okamura, Tomoya Maeda, Yuichi Sugahara, Motohiro Misumi, Katsuhiko Yoshida, Yuichi Nakamura, Nobutaka Kawai, Akira Matsuda, Itsuro Jinnai, Masami Bessho
Journal: Blood (2004)
Rapid Increase of CD8+ T Cell Count in Peripheral Blood of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia
Authors: Antonella Isgrò, Marco Marziali, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Maria Domenica Simone, Gioia De Angelis, Cecilia Alfieri, Cristiano Gallucci, Andrea Roveda, Fabio Torelli, Luisa Cardarelli, Michela Ribersani, Guido Lucarelli
Journal: Blood (2012)
Effect of a Novel NMDA Receptor Modulator, Rapastinel (Formerly GLYX-13), in OCD: Proof of Concept
Authors: Carolyn I. Rodriguez, Jordana Zwerling, Eyal Kalanthroff, Hanyang Shen, Maria Filippou, Booil Jo, Helen Blair Simpson, Ronald M. Burch, Joseph R. Moskal
Journal: American Journal of Psychiatry (2016)
P1223 : Frailty in children: A novel tool that measures the morbidity associated with end stage liver disease
Authors: B.M. Kamath, C. Quammie, J.F. Daniel, E.M. Alonso, E. Hsu, K. Furuya, N. Gupta, G.W. Telega, L. Book, H. Lin, S. Sundaram, J. Yap, T. Miloh, M. Englesbe, C. Sonneday, V. Ng
Journal: Journal of Hepatology (2015)
Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
Authors: Steven E. Come, Aman U. Buzdar, Carlos L. Arteaga, Angela M. Brodie, Nancy E. Davidson, Mitch Dowsett, James N. Ingle, Stephen R. D. Johnston, Adrian V. Lee, C. Kent Osborne, Kathleen I. Pritchard, Victor G. Vogel, Eric P. Winer, Carol S. Hart
Journal: Clinical Cancer Research (2003)

The Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer, co-chaired by Drs. Aman Buzdar and Steven Come,was held in Cambridge, Massachusetts, June 28-29,2002.

The conference was organized with the objective of analyzing new preclinical
Why Are Prospective Longitudinal Studies Needed in Preterm Behavioral Epigenetic Research?
Authors: Livio Provenzi, Renato Borgatti, Rosario Montirosso
Journal: JAMA Pediatrics (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Pediatrics HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Pediatrics journal
Phase 1 Trial of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
Authors: Asma Anwar, Anna B. Halpern, Megan Othus, Bart L. Scott, Paul C. Hendrie, Pamela S. Becker, Andrea M. Perdue, Heather A. Smith, Tara L. Chen, Sarah A. Buckley, Kaysey F. Orlowski, Morgan A. Powell, Elihu H. Estey, Roland B. Walter
Journal: Blood (2015)
Initiation of a Pre-Clinical Gene Therapy Study in Non-Human Primates Using Lentivectors Targeting Hematopoietic Cells for Correction of Fabry Disease.
Authors: Jagdeep S. Walia, Makoto Yoshimitsu, Josh D. Silvertown, Armando Poeppl, Vanessa I. Rasaiah, Robert E. Donahue, Robert G. Andrews, J. Andrea McCart, Jeffrey A. Medin
Journal: Blood (2005)
Toll-Like Receptor (TLR) Signaling Adaptor Protein MYD88 in Myelodysplastic Syndromes (MDS)
Authors: Sophie Dimicoli, Yue Wei, Rui Chen, Carlos E. Bueso-Ramos, Sherry A. Pierce, Hui Yang, Yu Jia, Hong Zheng, Zhihong Fang, Irene ganan-Gomez, Martin Nguyen, Michael Fernandez, Hagop M. Kantarjian, Guillermo Garcia-Manero
Journal: Blood (2012)
Topoisomerase IIα (TopoIIα) Expression in Hodgkin’s Lymphoma (HL): Correlations with Conventional and Biological Markers and Prognostic Significance under Treatment with ABVD or Equivalent Regimens with or without Radiotherapy (RT).
Authors: Theodoros P. Vassilakopoulos, Ipatia A. Doussis-Anagnostopoulou, Despina Karandrea, Penelope Korkolopoulou, Maria K. Angelopoulou, Marina P. Siakantaris, Styliani I. Kokoris, Evangelia M. Dimitriadou, Maria N. Dimopoulou, Christina Kalpadaki, Maria-Christina Kyrtsonis, Irini Thymara, Nikolaos Kavantzas, Panayiotis Panayiotidis, Efstratios Patsouris, Christos Kittas, Gerassimos A. Pangalis
Journal: Blood (2005)
FVIII Specific Memory B Lymphocytes in Hemophilia A with Inhibitors Treated by Immune Tolerance Induction.
Authors: Isabelle Diaz, Karine Bollore, Chantal Rothschild, Hervé Chambost, Ségolène Claeyssens, Edouard Tuaillon, Priscilla Lapalud, Jean-François Schved, Jean-Pierre Vendrell, Géraldine Lavigne-Lissalde
Journal: Blood (2009)
Transcriptional Activity of MEF/ELF4 on the HDM2 Promoter Is Enhanced by the Mutation of the NPM1 Gene
Authors: Koji Ando, Emi Matsuo, Kensuke Horio, Shinya Tominaga, Daisuke Imanishi, Yoshitaka Imaizumi, Hideki Tsushima, Masako Iwanaga, Hitoshi Kiyoi, Tomoki Naoe, Yasushi Miyazaki
Journal: Blood (2010)
Analysis T Cell Receptor Excision Circles (TRECs) in Patients with Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation.
Authors: Xin Du, Yangqiu Li, Jianyu Weng, Zesheng Lu, Rong Guo, Shaohua Chen, Lijian Yang, Suxia Geng, Zhilun Huang
Journal: Blood (2006)
The In Vivo Impact of Human Regulatory T Cells on the Graft Versus Tumor Effect.
Authors: Tuna Mutis, Henk Rozemuller, Maarten E. Emmelot, Tineke Aarts-Riemens, Vivienne Verweij, Saskia Ebeling, Leo F. Verdonck, Henk Lockhorst, Anton Martens
Journal: Blood (2007)
Rapid detection and evolutionary analysis of Legionella pneumophila serogroup 1 sequence type 47
Authors: M. Mentasti, P. Cassier, S. David, C. Ginevra, L. Gomez-Valero, A. Underwood, B. Afshar, J. Etienne, J. Parkhill, V. Chalker, C. Buchrieser, T.G. Harrison, S. Jarraud
Journal: Clinical Microbiology and Infection (2016)
Sp1 Inhibition Affects Cell Growth and Survival In Waldenstrom’s Macroglobulinemia Through a MYD88-Independent Pathway
Authors: Mariateresa Fulciniti, Rajya Bandi, Nicola Amodio, Rao H. Prabhala, Mansa Munshi, Lian Xu, Guang Yang, Zachary Hunter, Kenneth C. Anderson, Steven Peter Treon, Nikhil C. Munshi
Journal: Blood (2013)
Addition of Umbilical Cord Blood (UCB) Unit to Reduced Intensity Conditioning (RIC) Regimen to Augment Graft Versus Tumor (GVT) in Patients (pts) with Advanced Hematologic Malignancies
Authors: Partow Kebriaei, Sergio Giralt, Dan Jones, Karla Gutierrez, Marcos De Lima, Martin Korbling, Issa F. Khouri, Uday Popat, Muzaffar H. Qazilbash, Amin Alousi, Stefan O Ciurea, Laurence Cooper, Elizabeth Shpall, Richard Champlin
Journal: Blood (2008)
Targeting Myeloproliferative Diseases with JAK2 Inhibitors.
Authors: Vadim Markovtsov, Diane Yu, Marina Gelman, Wayne Lang, Vanessa C. Taylor, Stacey Huynh, Roy Frances, Shuling Fang, John McLaughlin, Sohasekhar Bhamidipati, Jeffrey Clough, Rajinder Singh, Gary Park, David Sweeney, Elizabeth Tonkin, Rena Bahjat, Betty Chang, Polly Pine, Ruby Daniel, Donald G. Payan, Sacha Holland, Yasumichi Hitoshi
Journal: Blood (2007)
PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003
Authors: Nicola Goekbuget, Anja Baumann, Joachim Beck, Monika Brueggemann, Helmut Diedrich, Andreas Huettmann, Lothar Leimer, Stefan Zewen, Martin Mohren, Albrecht Reichle, Markus Schaich, Kerstin Schaefer-Eckart, Marc Schmalzing, Mathias Schmid, Hubert Serve, Reingard Stuhlmann, Theis H Terwey, Dieter Hoelzer
Journal: Blood (2010)
Effects of Renal Impairment on the Pharmacology of Rivaroxaban (BAY 59-7939) - An Oral, Direct, Factor Xa Inhibitor.
Authors: Atef Halabi, Haidar Maatouk, Norbert Klause, Volkmar Lufft, Dagmar Kubitza, Michael Zuehlsdorf, Michael Becka, Wolfgang Mueck, Rafael Schäfers, Dominic Wand, Thomas Philipp, Heike Bruck
Journal: Blood (2006)
Development Of Second Generation Thiol Isomerase Inhibitors To Prevent Thrombus Formation
Authors: Daniel R Kennedy, Partha P Nag, Christine N. Galinski, Sheryl Bowley, Roelof H. Bekendam, James R. Dilks, Alissa A Scalise, Lotte van Hessem, Jun Pu, Tatiana Pilyugina, Sivaraman Dandapani, Benito Munoz, Robert Flaumenhaft
Journal: Blood (2013)
Reflections From a Primary Care Physician and Psychiatrist on a Framework for Extending Psychiatrists’ Roles in Treating General Health Conditions
Authors: Paul Rosen
Journal: American Journal of Psychiatry (2016)

course of his lifetime, had taken typical and atypical antipsychotics, topiramate, and antidepressants and had had comorbid hypercholesterinemia.The younger patient (YGTSS score595; TTS545; CGI score56 on admission day) had been taking 20 mg/day of aripiprazole for more than 4 years without sufficient improvement.Because of comorbid generalized anxiety disorder, both patients were started on a dosage of 100 mg/day of pregabalin, which was increased to 600 mg/day from treatment day 4 onward.Because of insomnia, the older patient received 100 mg of quetiapine at night.In the younger patient, aripiprazole was reduced to 10 mg/day and, because of depressive symptoms, sertraline at 50 mg/day was administered.The older patient's YGTSS score scaled down to 45 (TTS525), and his CGI score was 4; the younger patient had a YGTSS score of 58 (TTS528) and a CGI score of 4 only 7 days after onset of treatment.After these interesting observations, we treated a third patient with Tourette's syndrome without comorbidities (22 years old, Caucasian male; he was medication free for 5 years but, over his lifetime, had taken risperidone and valproate).On admission day, he scored 79 on the YGTSS (TTS539) and 6 on the CGI.He received pregabalin as described above and experienced a marked reduction in tic intensity and frequency only 7 days after onset of treatment (YGTSS score541; TTS521; CGI score54).None of the patients reported any side effects.All subjects provided written informed consent for anonymized publication of their data.In all three severely ill patients with Tourette's syndrome, pregabalin distinctly alleviated vocal and motor tics within 7 days of treatment.In summary, pregabalin has the potential to be an effective and well-tolerated new treatment option for this sometimes highly disabling neuropsychiatric disorder.Randomized controlled trials are needed to confirm these preliminary observations.
An Open-Label Phase I Study of the Safety and Efficacy of RAD001 in Combination with Lenalidomide in the Treatment of Patients with Relapsed and Relapsed/Refractory Multiple Myeloma.
Authors: Noopur Raje, Paul Richardson, Parameswaran N Hari, Anuj Mahindra, Sarah Kaster, Christine Connolly, Linda Rivera, Gaurav Chetri, Sarah Dean, Paulette Jacobs, Ayman Saad, Jacob Laubach, Irene M. Ghobrial, Robert L Schlossman, Jennifer Adams, Wendy Makrides, Edie Weller, Nikhil Munshi, Kenneth C. Anderson
Journal: Blood (2009)
A Phase I Trial of the Epigenetic Modulators Vorinostat, in Combination with Azacitidine (azaC) in Patients with the Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML): A Study of the New York Cancer Consortium
Authors: Lewis R. Silverman, Amit Verma, Rosalie Odchimar-Reissig, Amanda LeBlanc, Vesna Najfeld, Janice Gabrilove, Luis Isola, Igor Espinoza-Delgado, James Zwiebel
Journal: Blood (2008)
Prospects for Dendritic Cell Vaccination Against Fungal Infections in Hematopoietic Transplantation.
Authors: Katia Perruccio, Silvia Bozza, Claudia Montagnoli, Silvia Bellocchio, Franco Aversa, Massimo F. Martelli, Francesco Bistoni, Andrea Velardi, Luigina Romani
Journal: Blood (2004)
Non-Ablative or Reduced Intensity Conditioning Regimens with Volunteer Unrelated Donor Progenitor Cell Transplantation.
Authors: Sergio Giralt, Brent Logan, Mei-Jei Zhang, Olivia McGaha, Karen Ballen, Christos Emmanouilides, Rajneesh Nath, Pablo Miguel Parker, David Porter, Brenda Sandmaier, Edmund Waller, Juliet Barker, Steven Pavletic, Daniel Weisdorf
Journal: Blood (2004)
Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years
Authors: Ifigeneia Tzannou, Bilal Omer, Anastasia Papadopoulou, Ulrike Gerdemann, Colton Smith, Adrian P. Gee, Bambi J Grilley, Malcolm K. Brenner, Catherine M. Bollard, Ann M. Leen, Cliona M. Rooney, Helen E. Heslop
Journal: Blood (2015)
Differences in the Pattern of Histone H3 (K4) and (K27) Methylation throughout the β-Globin Gene Locus in Baboon Fetal Liver and Adult Bone Marrow Erythroblasts Pre- and Post-Decitabine Treatment.
Authors: Janet Chin, Donald Lavelle, Kestis Vaitkus, Maria Hankewych, Joseph DeSimone
Journal: Blood (2006)
The Presence of FDG PET/CT Focal, Not Osteolytic, Lesion(s) Identifies a Sub-Group of Patients with Smoldering Multiple Myeloma with High-Risk of Progression into Symptomatic Disease
Authors: Elena Zamagni, Cristina Nanni, Francesca Gay, Annalisa Pezzi, Marilena Bellò, Ilaria Rambaldi, Paola Tacchetti, Annamaria Brioli, Lucia Pantani, Valeria Magarotto, Beatrice Anna Zannetti, Massimo Menga, Giulia Marzocchi, Carolina Terragna, Katia Mancuso, Antonio Palumbo, Stefano Fanti, Michele Cavo
Journal: Blood (2014)
Fruitful analysis of sex chromosomes reveals X-treme genetic diversity
Authors: Angela M. Taravella, Melissa A. Wilson Sayres
Journal: Genome biology (2016)

A new study on sex chromosome evolution in papaya helps to illuminate sex chromosome biology, including deviations from expected trajectories. Please see related Research article: https://genomebiology.biomedcentral.com/articles/10.1186/s13059-016-1095-9
Copenhagen five-second squeeze: a valid indicator of sports-related hip and groin function
Authors: K Thorborg, S Branci, M P Nielsen, M T Langelund, P Hölmich
Journal: British Journal of Sports Medicine (2016)

Background No simple clinical measure exits to evaluate groin pain and its severity in athletes. The aim was to investigate the validity, reliability and responsiveness of a five-second hip-adduction squeeze test for football players designed to assess sports-related hip and groin function, pain and severity. Methods Construct validity was assessed in 667 subelite male football players with a mean age (±SD) of 24±4 in the beginning of the season. Responsiveness and reliability were evaluated during the season in 52 and 10 players, respectively. Players answered the Copenhagen Hip and Groin Outcome Score (HAGOS) and performed the Copenhagen five-second squeeze assessed on a Numerical Pain Rating Scale (NRS) ranging from 0 to 10. Results As hypothesised higher pain scores during the Copenhagen five-second squeeze correlated significantly (Spearman's rho=−0.61, p&lt;0.01) with a lesser HAGOS (Sport) Score. The change scores in the Copenhagen five-second squeeze also correlated significantly (Spearman's rho=−0.51, p&lt;0.01), with HAGOS (Sport) change scores in the responsiveness analysis, and test–retest reliability (concordance correlation coefficient) was 0.90. Moreover, significant (p&lt;0.01) between-group differences existed for HAGOS (Sport) Scores in players reporting groin pain intensity at one of the 3 different pain levels: NRS (0–2), NRS (3–5) and NRS (6–10). The NRS (6–10) group had the lowest median (IQR) HAGOS (Sport) Score of 47 (31–61). Conclusions The Copenhagen five-second squeeze is a valid indicator of sports-related hip and groin function in football players. Players reporting groin pain intensity as 6 of 10 or more in the Copenhagen five-second squeeze experience substantially impaired sports-related hip and groin function.
Trends in Human T-Cell Leukemia Virus Type-1 (HTLV-1) Prevalence and the Incidence of Adult T-Cell Leukemia/Lymphoma (ATL) in Nagasaki, Japan: A Hospital-Based and Population-Based Study.
Authors: Masako Iwanaga, Yoshito Koga, Midori Soda, Naoko Inokuchi, Daisuke Sasaki, Hiroo Hasegawa, Katsunori Yanagihara, Kazunari Yamaguchi, Shimeru Kamihira, Yasuaki Yamada
Journal: Blood (2009)
A Phase II Trial of Azacitidine (NSC-102816) and Gemtuzumab Ozogamicin (NSC-720568) As Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia (SWOG S0703): Report On the Poor Risk Patients
Authors: Sucha Nand, Megan Othus, John E. Godwin, Cheryl L Willman, Thomas Norwood, Harry Paul Erba, Dianna Howard, Steven E. Coutre, Frederick R. Appelbaum
Journal: Blood (2012)
A Phase I Trial of Dose Escalating Simvastatin Combined with Chemotherapy in End-Stage Myeloma and Lymphoma.
Authors: Henk M. Lokhorst, Niels van de Donk, Ellen van de Spek, Okke de Weerdt, Rene van de Griend, Shulamiet Wittebol, Leo F. Verdonck, Andries C. Bloem
Journal: Blood (2004)
HLA Disparity Is Associated with Improved Outcomes in Hematological Malignancies After Family HLA-Mismatched /Haploidentical HCT but Not URD
Authors: Lujia Dong, Zhi-Yong Gao, Xin-Jian Yu, Xi-You Tan, Jin-Hong Liu, Fengjuan Lu, Yi Xie, Lung-Ji Chang, Ling Zhou, Wen-Rong Lu, Can Tong, Yuan-Ying Zeng, Shuang Hou, Na Xu, Xue Yan, Dao-Pei Lu
Journal: Blood (2012)
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Authors: Richard A. Nash, George J Hutton, Michael K Racke, Uday R Popat, Steven M. Devine, Linda M. Griffith, Paolo A Muraro, Harry Openshaw, Peter H. Sayre, Olaf Stuve, Douglas L Arnold, Lisa Wruck, Annette Wundes, George H Kraft, James D Bowen
Journal: Blood (2011)
Prior Therapy with Rituximab Correlates with Less Acute Graft-Versus-Host Disease and Better Survival in B-Cell Lymphoma Patients Who Received Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).
Authors: Voravit Ratanatharathorn, Mary M. Horowitz, Brian Logan, Mukta Arora, Dan Wang, Joseph P. Uberti, Robert P. Gale, Joseph H. Antin, Martin Bornhaeuser, Gregory A. Hale, Olle Ringden, Mitchell S. Cairo, Vikas Gupta, Corey Cutler, Claudio Anasetti, Steven Z. Pavletic
Journal: Blood (2007)
Nongastric Marginal Zone B-Cell Lymphoma: A Prognostic Model from a Retrospective Multicenter Study.
Authors: Sung Yong Oh, Hyuk-Chan Kwon, Won Seog Kim, Yeon Hee Park, Kihyun Kim, Sung-Hyun Kim, Hyun Jung Kim, Jung Mi Kwon, Jeeyun Lee, Young Hye Ko, Yong Chan Ahn, Suk Joong Oh, Soon Il Lee, Soo Mee Bang, Jung Han Kim, Jinny Park, Baek-Yeol Ryoo, Seung-Sook Lee, Ho Young Kim, Hyo-Jin Kim
Journal: Blood (2007)
Chromosomal Instability Causes Genetic and Clonal Heterogeneity in Myeloproliferative Neoplasms and Is Not Restricted to JAK2-V617F Positive Cells
Authors: Roland Jäger, Damla Olcaydu, Tiina Berg, Bettina Gisslinger, Heinz Gisslinger, Robert Kralovics
Journal: Blood (2008)
A brush-polymer/exendin-4 conjugate reduces blood glucose levels for up to five days and eliminates poly(ethylene glycol) antigenicity
Authors: Yizhi Qi, Antonina Simakova, Nancy J. Ganson, Xinghai Li, Kelli M. Luginbuhl, Imran Ozer, Wenge Liu, Michael S. Hershfield, Krzysztof Matyjaszewski, Ashutosh Chilkoti
Journal: Nature Biomedical Engineering (2016)
Clinical Factors Predictive Of Myelofibrotic Evolutions In Patients With Essential Thrombocythemia and Polycythemia Vera
Authors: Mario Tiribelli, Federico De Marchi, Daniela Barraco, Luciana Marin, Erika Codarin, Silvia Buttignol, Daniela Damiani, Renato Fanin
Journal: Blood (2013)
Langerhans Cell Histiocytosis with Hematological Dysfunction, Refractory to Standard Therapy Could Be Cured by an Association of 2-CdA and Ara-C: Concordant Results from the Observational Survey of Treated Patients and from a Nation Wide Registry.
Authors: Jean Donadieu, C. Thomas, V. Barlogis, C. Galambrun, A. Robert, V. Gandemer, Y. Bertrand, M. Munzer, J. Landman-Parker, M. Ouache-Chardin, Y. Perel, P. Chastagner, A. Fischer, F. Bernard
Journal: Blood (2007)
Clinical Development of MGCD0103, An Isotype-Selective HDAC Inhibitor: Pericarditis/Pericardial Effusion in the Context of Overall Safety and Efficacy.
Authors: Robert E. Martell, Guillermo Garcia-Manero, Anas Younes, Michael Ewer, Iyad N Daher, Michel Drouin, Wendy Hunt, Karine Lortie, Jennifer Wilhelm, Jeffrey M. Besterman
Journal: Blood (2009)
Clinical Impact of First Complete Remission (CR1) Duration on Outcome of Patients with Relapsed Philadelphia Negative Pre-B Acute Lymphoblastic Leukemia (ALL)
Authors: Guillermo Montalban-Bravo, Hagop M. Kantarjian, Jorge E. Cortes, Farhad Ravandi, Guillermo Garcia-Manero, Jain Punit, Naveen Pemmaraju, Gautam Borthakur, Tapan Kadia, Marina Konopleva, Sherry Pierce, Susan O'Brien, Elias Jabbour
Journal: Blood (2015)